Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma

International Journal of Radiation Oncology Biology Physics

Volumn 51, Issue 1, 2001, Pages 138-147

  Egger, Emmanuel ^a   Schalenbourg, Ann ^a,b   Zografos, Leonidas ^b   Bercher, Ludmila ^b   Boehringer, Terence ^a   Chamot, Line ^b   Goitein, Gudrun ^a  

^a PAUL SCHERRER INSTITUTE   (Switzerland)

^b HÔPITAL OPHTALMIQUE JULES GONIN   (Switzerland)

Author keywords

Local tumor control; Proton beam radiotherapy; Results; Survival; Uveal melanoma

Indexed keywords

DISEASE CONTROL; PATIENT TREATMENT; PROTON BEAMS; RADIOTHERAPY; TANTALUM;

UVEAL MELANOMA;

TUMORS;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CONTROL; CILIARY BODY TUMOR; CONTROLLED STUDY; DATA ANALYSIS; DEATH; EYE TUMOR; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTON RADIATION; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR RECURRENCE; TUMOR VOLUME; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; CILIARY BODY; EYELIDS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; PROTONS; RISK FACTORS; SEX FACTORS; SURVIVAL RATE; TIME FACTORS; UVEAL NEOPLASMS;

EID: 0035450791     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01560-7     Document Type: Article

References (35)

1. The treatment of primary intraocular malignancy
2. Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection
3. Brachytherapy of choroidal hemangiomas
4. Episcleral plaque radiotherapy in the treatment of uveal melanomas
5. 106Rh) of choroidal melanomas: 20 Years' experience
6. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement
7. Fractionated stereotactic radiotherapy for choroidal melanoma
8. Stereotactic irradiation of uveal melanoma with the Leksell gamma unit
9. Precision, high dose radiotherapy: Helium ion treatment of uveal melanoma
10. Long-term results of helium ion irradiation of uveal melanoma
11. Long-term results of proton beam irradiated uveal melanomas
12. Proton therapy for uveal melanomas and other eye lesions
13. Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy
14. Proton beam irradiation: An alternative to enucleation for intraocular melanomas
15. Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation
16. Helium ion versus iodine 125 brachytherapy in the management of uveal melanoma
17. Long term visual outcome of radiated uveal melanomas in eyes eligible for randomisation to enucleation versus brachytherapy
18. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma
19. Impact of enucleation versus plaque radiotherapy in the management of juxtapapillary choroidal melanoma on patient survival
20. Enucleation versus plaque irradiation for choroidal melanoma
21. Malignant melanomas of the human uvea: 25 Year follow-up of cases in Denmark, 1943-1952
22. Planning proton therapy of the eye
23. The therapy planning program EYE
24. EYEPLAN proton therapy planning program
25. Conservative treatment of uveal melanoma: Local recurrence after proton beam therapy
26. Long-term follow-up after uveal melanoma charged particle therapy
27. Ten-year follow-up of helium ion therapy for uveal melanoma
28. Results of proton therapy of uveal melanomas treated in Nice
29. Clinical and technical requirements for proton treatment planning of ocular disease
30. Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement
31. 60Co episcleral plaque therapy
32. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma
33. Potential for improving survival rates for the cancer patient by increasing the efficacy of treatment of the primary lesion
34. Impact of improved local control on survival
35. Local control and patient survival